10-K Filing

BNB PLUS CORP. CIK: 744452 FY 2011

Filing Information

Form Type	10-K
Accession Number	`0001188112-11-003443`
Period End Date	20110930
Filing Date	20111209
Fiscal Year	2011
Fiscal Period	FY
XBRL Instance	apdn-20110930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 24 Cash Flow Statement 47 Stockholders Equity 23

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation on Property, plant and equipment (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$207.10K	USD	Point-in-time
Accumulated depreciation on Property, plant and equipment (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$210.86K	USD	Point-in-time
Accumulated amortization on Capitalized finance costs (in dollars)	`AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts`	$1.81M	USD	Point-in-time
Accumulated amortization on Capitalized finance costs (in dollars)	`AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts`	$947.28K	USD	Point-in-time
Cash and cash equivalents	`Cash`	$17.62K	USD	Point-in-time
Accumulated amortization on Patents (in dollars)	`FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff`	$34.26K	USD	Point-in-time
Cash and cash equivalents	`Cash`	$2.75M	USD	Point-in-time
Accumulated amortization on Patents (in dollars)	`FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff`	$34.26K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$63.03K	USD	Point-in-time
Accumulated amortization and write off on Intellectual property (in dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$9.16M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$208.59K	USD	Point-in-time
Accumulated amortization and write off on Intellectual property (in dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$8.79M	USD	Point-in-time
Unamortized discount on Convertible notes payable, current (in dollars)	`UnamortizedDiscountOnConvertibleNotesPayableCurrent`	$545.92K	USD	Point-in-time
Unamortized discount on Convertible notes payable, current (in dollars)	`UnamortizedDiscountOnConvertibleNotesPayableCurrent`	$541.12K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$161.46K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$76.29K	USD	Point-in-time
Unamortized discount on Convertible note payable-related party, non-current (in dollars)	`UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent`	$5.29K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$242.10K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.03M	USD	Point-in-time
Unamortized discount on Convertible note payable-related party, non-current (in dollars)	`UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent`	$5.29K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property, plant and equipment-net of accumulated depreciation of $210,862 and $207,097 respectively	`PropertyPlantAndEquipmentNet`	$3.77K	USD	Point-in-time
Property, plant and equipment-net of accumulated depreciation of $210,862 and $207,097 respectively	`PropertyPlantAndEquipmentNet`	$89.11K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Deposits	`DepositAssets`	$23.46K	USD	Point-in-time
Deposits	`DepositAssets`	$8.32K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Capitalized finance costs-net of accumulated amortization of $1,806,261 and $947,276, respectively	`DeferredFinanceCostsNoncurrentNet`	$522.49K	USD	Point-in-time
Capitalized finance costs-net of accumulated amortization of $1,806,261 and $947,276, respectively	`DeferredFinanceCostsNoncurrentNet`	$85.97K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Patients, net of accumulated amortization of $34,257 (Note B)	`FiniteLivedPatentsIntangibleAssetsNet`	-	USD	Point-in-time
Patients, net of accumulated amortization of $34,257 (Note B)	`FiniteLivedPatentsIntangibleAssetsNet`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	800.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	800.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	473.33M	shares	Point-in-time
Intellectual property, net of accumulated amortization and write off of $9,158,056 and $8,794,265, respectively (Note B)	`FiniteLivedIntangibleAssetsNet`	$636.63K	USD	Point-in-time
Intellectual property, net of accumulated amortization and write off of $9,158,056 and $8,794,265, respectively (Note B)	`FiniteLivedIntangibleAssetsNet`	$272.84K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	346.37M	shares	Point-in-time
Total Assets	`Assets`	$1.41M	USD	Point-in-time
Total Assets	`Assets`	$3.50M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	473.33M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	346.37M	shares	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$768.06K	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$967.55K	USD	Point-in-time
Advances from Officers (Note E)	`DueToOfficersOrStockholdersCurrent`	$50.00K	USD	Point-in-time
Convertible notes payable, net of unamortized discount of $541,120 and $545,920, (Note D)	`ConvertibleNotesPayableCurrent`	$3.73M	USD	Point-in-time
Convertible notes payable, net of unamortized discount of $541,120 and $545,920, (Note D)	`ConvertibleNotesPayableCurrent`	$1.77M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.79M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.50M	USD	Point-in-time
Convertible note payable-related party, net of unamortized discount of $5,286	`NotesPayableRelatedPartiesNoncurrent`	$219.71K	USD	Point-in-time
Commitments and contingencies (Note H)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note H)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of September 30, 2011 and September 30, 2010	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of September 30, 2011 and September 30, 2010	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 800,000,000 shares authorized; 473,325,859 and 346,366,244 issued and outstanding as of September 30, 2011 and 2010, respectively	`CommonStockValue`	$346.37K	USD	Point-in-time
Common stock, par value $0.001 per share; 800,000,000 shares authorized; 473,325,859 and 346,366,244 issued and outstanding as of September 30, 2011 and 2010, respectively	`CommonStockValue`	$473.33K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$149.40M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$160.39M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-161.86M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-151.34M	USD	Point-in-time
Total deficiency in stockholders' equity	`StockholdersEquity`	$-995.38K	USD	Point-in-time
Total deficiency in stockholders' equity	`StockholdersEquity`	$-1.75M	USD	Point-in-time
Total deficiency in stockholders' equity	`StockholdersEquity`	$-1.60M	USD	Point-in-time
Total Liabilities and Deficiency in Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$1.41M	USD	Point-in-time
Total Liabilities and Deficiency in Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$3.50M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	$968.85K	USD	Annual
Revenue	`SalesRevenueNet`	$519.84K	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$8.39M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$7.19M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$75.96K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$268.88K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$371.91K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$367.56K	USD	Annual
Total operating expenses	`OperatingExpenses`	$7.64M	USD	Annual
Total operating expenses	`OperatingExpenses`	$9.03M	USD	Annual
NET LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-7.12M	USD	Annual
NET LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-8.06M	USD	Annual
Interest expense, net	`InterestExpense`	$792.55K	USD	Annual
Interest expense, net	`InterestExpense`	$2.46M	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.91M	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.52M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	Annual
NET LOSS	`NetIncomeLoss`	$-7.91M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-10.52M	USD	Annual
Net loss per share-basic and fully diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	Annual
Net loss per share-basic and fully diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	Annual
Weighted average shares outstanding-Basic and fully diluted (in shares)	`WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne`	376.83M	shares	Annual
Weighted average shares outstanding-Basic and fully diluted (in shares)	`WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne`	300.35M	shares	Annual

Cash Flow Statement 47 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-7.91M	USD	Annual
Net loss	`NetIncomeLoss`	$-10.52M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$367.56K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$371.91K	USD	Annual
Fair value of vested options issued to officers, directors and employees	`VestedOptionsIssuedToOfficersDirectorsAndEmployees`	$1.49M	USD	Annual
Fair value of vested options issued to officers, directors and employees	`VestedOptionsIssuedToOfficersDirectorsAndEmployees`	$2.55M	USD	Annual
Amortization of capitalized financing costs	`AmortizationOfFinancingCosts`	$331.67K	USD	Annual
Amortization of capitalized financing costs	`AmortizationOfFinancingCosts`	$858.99K	USD	Annual
Amortization of debt discount attributable to convertible debentures	`AmortizationOfDebtDiscountPremium`	$512.53K	USD	Annual
Amortization of debt discount attributable to convertible debentures	`AmortizationOfDebtDiscountPremium`	$2.10M	USD	Annual
Equity based compensation	`ShareBasedCompensation`	$1.25M	USD	Annual
Equity based compensation	`ShareBasedCompensation`	$1.44M	USD	Annual
Common stock issued in settlement of interest	`CommonStockIssuedInSettlementOfInterest`	$195.79K	USD	Annual
Common stock issued in settlement of interest	`CommonStockIssuedInSettlementOfInterest`	$37.00K	USD	Annual
Fair value change from employee option modifications	`FairValueOptionChangesInFairValueGainLoss`	$-738.81K	USD	Annual
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$145.56K	USD	Annual
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$15.73K	USD	Annual
Decrease in prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-31.86K	USD	Annual
Decrease in prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-70.03K	USD	Annual
(Decrease) increase in accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-199.49K	USD	Annual
(Decrease) increase in accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$230.11K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.46M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.76M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$89.11K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-89.11K	USD	Annual
Net proceeds from (repayments of) related party advances	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$50.00K	USD	Annual
Net proceeds from (repayments of) related party advances	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-50.00K	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$4.74M	USD	Annual
Net proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$2.21M	USD	Annual
Net proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$1.90M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.26M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$6.58M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.73M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-195.69K	USD	Annual
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$213.31K	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$17.62K	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.75M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$213.31K	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$17.62K	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$2.75M	USD	Point-in-time
Cash paid during the year for interest	`InterestPaid`	-	USD	Annual
Cash paid during the year for interest	`InterestPaid`	-	USD	Annual
Cash paid during the year for taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during the year for taxes	`IncomeTaxesPaid`	-	USD	Annual
Fair value of warrants issued for financing costs	`WarrantsIssuedForFinancingCosts`	$217.97K	USD	Annual
Common stock issued in exchange for previously incurred debt	`DebtConversionConvertedInstrumentAmount1`	$410.00K	USD	Annual
Common stock issued in exchange for previously incurred debt	`DebtConversionConvertedInstrumentAmount1`	$3.03M	USD	Annual

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-995.38K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.75M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.60M	USD	Point-in-time
Equity based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.25M	USD	Annual
Equity based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$502.08K	USD	Annual
Fair value of vested options issued to officers, directors and employees	`VestedOptionsIssuedToOfficersDirectorsAndEmployees`	$1.49M	USD	Annual
Fair value of vested options issued to officers, directors and employees	`VestedOptionsIssuedToOfficersDirectorsAndEmployees`	$2.55M	USD	Annual
Fair value of vested warrants issued for services	`FairValueOfVestedWarrantsIssuedForServices`	$288.31K	USD	Annual
Fair value of vested warrants issued for services	`FairValueOfVestedWarrantsIssuedForServices`	$217.97K	USD	Annual
Beneficial conversion feature relating to convertible debentures	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$744.15K	USD	Annual
Beneficial conversion feature relating to convertible debentures	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$2.09M	USD	Annual
Common stock issued in settlement of convertible debentures	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$3.03M	USD	Annual
Common stock issued in settlement of convertible debentures	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$410.00K	USD	Annual
Common stock issued in exchange for consulting services	`StockIssuedDuringPeriodValueExchangeForConsultingServices`	$197.84K	USD	Annual
Common stock issued in exchange for consulting services	`StockIssuedDuringPeriodValueExchangeForConsultingServices`	$65.00K	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$4.74M	USD	Annual
Common stock issued as officer compensation	`CommonStockIssuedValueOfficerCompensation`	$877.50K	USD	Annual
Fair value change from employee option modifications	`FairValueOptionChangesInFairValueGainLoss`	$-738.81K	USD	Annual
Net loss	`NetIncomeLoss`	$-7.91M	USD	Annual
Net loss	`NetIncomeLoss`	$-10.52M	USD	Annual
Balance	`StockholdersEquity`	$-995.38K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.75M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.60M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.